| Chapter title |
Hallucinogens in Drug Discrimination
|
|---|---|
| Chapter number | 476 |
| Book title |
Current Topics in Behavioral Neurosciences
|
| Published in |
Current topics in behavioral neurosciences, May 2017
|
| DOI | 10.1007/7854_2017_476 |
| Pubmed ID | |
| Book ISBNs |
978-3-66-255878-2, 978-3-66-255880-5
|
| Authors |
Lisa E. Baker, Baker, Lisa E. |
| Abstract |
Hallucinogens comprise a diverse collection of chemicals with multifarious receptor actions in the central nervous system. Preclinical drug screening methods have proven invaluable in the evaluation and characterization of hallucinogen psychopharmacology. Used in concert with structural chemistry and receptor pharmacology methods, preclinical drug discrimination research has informed our current understanding of hallucinogens and the neurochemical receptor mechanisms responsible for their interoceptive stimulus effects. This chapter summarizes the strengths and limitations of drug discrimination as an in vivo drug detection method and offers a brief review of historical and contemporary drug discrimination research with classical hallucinogens. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 27 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 6 | 22% |
| Researcher | 5 | 19% |
| Student > Doctoral Student | 4 | 15% |
| Student > Master | 3 | 11% |
| Student > Ph. D. Student | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 8 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 6 | 22% |
| Psychology | 5 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
| Medicine and Dentistry | 2 | 7% |
| Agricultural and Biological Sciences | 1 | 4% |
| Other | 2 | 7% |
| Unknown | 9 | 33% |